Market Overview:
The global pain drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, technological advancements in drug delivery systems, and rising demand for minimally invasive procedures. The global pain drug delivery market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into transdermal drug delivery system (TDDS), intrathecal drug delivery system (IDDS), and others (including oral transmucosal fentanyl citrate [OTFC], rectal administration). TDDS held a dominant share in 2017 owing to its advantages such as ease of use and patient compliance. However, IDDS are expected to grow at a higher CAGR during the forecast period due to their benefits such as improved efficacy and reduced side effects as compared with other modes of administration. On the basis of application, the market is segmented into oncology, neurological disorders (such as chronic pain management), pulmonary diseases (such as asthma and COPD), hormonal disorders (such as diabetes mellitus type 2 [DM2] patients treated with insulin analogs via an IDDS device), and others including gastrointestinal diseases/conditions managed by oral medications or enteral nutrition products delivered through an OTFC device).
Product Definition:
Pain drug delivery is the process of delivering pain medication to a patient. This can be done through various means, including injection, oral ingestion, or topical application. The importance of pain drug delivery lies in its ability to provide relief to patients who are suffering from pain. By delivering medication directly to the site of injury or inflammation, it is possible to achieve faster and more effective relief than if the medication were taken orally or injected into the bloodstream.
Transdermal Drug Delivery System:
The transdermal drug delivery system is a method of delivering drugs to patients that are sensitive to traditional methods such as oral, intravenous and intramuscular routes. The transdermal route delivers the medication directly on the skin in a way that allows for greater absorption by the body compared to other routes of drug delivery.
Factors such as ease of use, patient compliance.
Intrathecal Drug Delivery System:
Intrathecal drug delivery system is used in pain management to deliver drugs at the site of chronic pain. It provides several advantages such as it allows for greater control over the amount of medication delivered, it reduces the intensity and frequency of pain signals that are sent to the brain, and helps reduce inflammation. The most commonly used intrathecal drug delivery systems include pumps (bacterial artificial membrane), reservoir devices, and injectable formulations.
Application Insights:
Oncology was the largest application segment in 2017 and is expected to maintain its lead over the forecast period. Increasing prevalence of cancer is one of the major factors driving this growth. According to WHO, it is estimated that globally 1 in 6 women and 1 in 5 men are diagnosed with cancer during their life span. Moreover, new drugs coming up for approval for pain management are expected to contribute towards market growth over the forecast period. For instance, Acetaminophen/Paracetamol (APAP) tablets & APAP gel are approved by FDA for neuropathic pain due to shingles post-herpetic neuralgia (PHN).
The hormonal disorders segment held a significant share as compared with other applications on a global level owing to an increase in hormone related diseases such as osteoporosis and menopausal symptoms like hot flashes.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments by companies and universities for development of advanced systems. In addition, rising prevalence of chronic pain conditions such as arthritis, cancer, and others are contributing towards regional growth.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to growing target population base with high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging countries such as China and India. Furthermore, availability of raw materials at a low cost will also help boost revenue generation in this region. Rising incidence of chronic pain conditions such as neuropathic pain due to diabetes or spinal cord injury are also driving factors for regional growth.
Growth Factors:
- Increasing prevalence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages. This will create a larger pool of patients who need treatment for their chronic pain, driving the demand for pain drug delivery devices and therapies.
- Advances in technology: Technological advances are making it possible to develop new and better ways to deliver drugs directly to the site of pain. This is helping to improve patient outcomes and increase the adoption of drug delivery devices and therapies.
- Growing focus on minimally invasive procedures: There is a growing focus on minimally invasive procedures, which are less invasive than traditional surgery and cause less trauma to the body. Drug delivery devices that can be used in minimally invasive procedures are likely to see increased demand in the coming years.
- Rising healthcare costs: The cost of healthcare continues to rise, putting pressure on healthcare providers and insurers alike To find ways reduce costs while still providing high-quality care To this end, they are increasingly turning towards more cost-effective drug delivery devices an therapies such as those offered by Pain Drug Delivery market players .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Drug Delivery Market Research Report
By Type
Transdermal Drug Delivery System, Intrathecal Drug Delivery System, Others
By Application
Oncology, Neurological Disorders, Pulmonary Diseases, Hormonal Disorders, Others
By Companies
Medtronic, Flowonix Medical, Aveva Drug Delivery Systems, Prosolus Pharmaceuticals, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Pain Drug Delivery Market Report Segments:
The global Pain Drug Delivery market is segmented on the basis of:
Types
Transdermal Drug Delivery System, Intrathecal Drug Delivery System, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Neurological Disorders, Pulmonary Diseases, Hormonal Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Flowonix Medical
- Aveva Drug Delivery Systems
- Prosolus Pharmaceuticals
- Teva Pharmaceutical Industries
Highlights of The Pain Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transdermal Drug Delivery System
- Intrathecal Drug Delivery System
- Others
- By Application:
- Oncology
- Neurological Disorders
- Pulmonary Diseases
- Hormonal Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pain drug delivery is the process of delivering medications to the site of pain where they can work most effectively.
Some of the major players in the pain drug delivery market are Medtronic, Flowonix Medical, Aveva Drug Delivery Systems, Prosolus Pharmaceuticals, Teva Pharmaceutical Industries.
The pain drug delivery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pain Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pain Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pain Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pain Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pain Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Pain Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Pain Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Transdermal Drug Delivery System
5.2.2 Intrathecal Drug Delivery System
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Neurological Disorders
6.2.3 Pulmonary Diseases
6.2.4 Hormonal Disorders
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pain Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pain Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Transdermal Drug Delivery System
9.6.2 Intrathecal Drug Delivery System
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Neurological Disorders
9.10.3 Pulmonary Diseases
9.10.4 Hormonal Disorders
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Transdermal Drug Delivery System
10.6.2 Intrathecal Drug Delivery System
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Neurological Disorders
10.10.3 Pulmonary Diseases
10.10.4 Hormonal Disorders
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Transdermal Drug Delivery System
11.6.2 Intrathecal Drug Delivery System
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Neurological Disorders
11.10.3 Pulmonary Diseases
11.10.4 Hormonal Disorders
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Transdermal Drug Delivery System
12.6.2 Intrathecal Drug Delivery System
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Neurological Disorders
12.10.3 Pulmonary Diseases
12.10.4 Hormonal Disorders
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Transdermal Drug Delivery System
13.6.2 Intrathecal Drug Delivery System
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Neurological Disorders
13.10.3 Pulmonary Diseases
13.10.4 Hormonal Disorders
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pain Drug Delivery Market: Competitive Dashboard
14.2 Global Pain Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Flowonix Medical
14.3.3 Aveva Drug Delivery Systems
14.3.4 Prosolus Pharmaceuticals
14.3.5 Teva Pharmaceutical Industries
